Visolyr Information

Visolyr® is built around Agentic Adaptive Intelligence™, helping clinicians navigate moments that matter by identifying early signs of cardiometabolic disease, analyzing evolving clinical patterns, and delivering evidence-based, context-aware insights they can independently review and apply. By unifying EMR data, diagnostics, social determinants of health, and unstructured clinical notes into a single intelligent engine, Visolyr enables earlier detection, proactive and personalized intervention, and measurable clinical and financial impact, including reduced avoidable complications. Our first release, KAIROS™, is a unified clinical intelligence platform that orchestrates autonomous AI agents to synthesize multimodal patient data and surface real-time, workflow-ready clinical insight at critical decision points. Designed to scale across rural clinics, ACOs, independent practices, and large health systems, KAIROS supports more confident decision-making while reducing cognitive burden and fitting naturally into existing clinical workflows. Visolyr partners with NVIDIA, Microsoft, OpenAI, Google, Anthropic and HITLAB to advance responsible, human-centered AI in cardiometabolic care.